MCAT content library / Biology & biochemistry / Antibodies and antigen presentation
Separate direct antigen binding from peptide presentation so a failed antibody assay and a failed T-cell assay are not mistaken for the same defect.
About 18 minutes, including the antigen-variant and MHC-presentation experiment.
Useful foundations
On this page
- Antibodies and T cells see antigen differently
- Concept: antibody specificity resides in variable binding regions
- Pattern: MHC presents peptides to T-cell receptors
- Worked application: one antigen, two recognition assays
- Rule: antigen presence and antigen presentation are different claims
- Check your reasoning
- Continue learning
- Sources
Antibodies and T cells see antigen differently
An antigen is a molecule or molecular structure that can be specifically recognized by immune receptors. An epitope is the particular region recognized by a given receptor or antibody. Antibodies and B-cell receptors can bind accessible structures on intact antigen. T-cell receptors, by contrast, generally recognize peptide fragments displayed on cell-surface MHC molecules rather than free intact protein.2
That distinction allows one mutation in an antigen to disrupt an antibody epitope while leaving a separate T-cell peptide epitope intact—or the reverse. “The antigen changed” is therefore not enough to predict every immune recognition assay.
Concept: antibody specificity resides in variable binding regions
A typical antibody contains two identical heavy chains and two identical light chains. The variable regions at the tips of the molecule create two antigen-binding sites with the same specificity, while constant regions participate in downstream effector functions and define immunoglobulin class. Antigen binding depends on noncovalent molecular complementarity between the binding site and epitope.
Changing an antibody’s antigen-binding region can therefore alter specificity or affinity without necessarily changing every downstream constant-region interaction. Conversely, changing an Fc-region function need not eliminate antigen binding. The structural location of the change matters.
Pattern: MHC presents peptides to T-cell receptors
MHC class I molecules are expressed on most nucleated cells and primarily present peptides derived from intracellular proteins to CD8 T cells. MHC class II molecules are concentrated on professional antigen-presenting cells such as dendritic cells, macrophages, and B cells and primarily present peptides derived from proteins taken up into vesicular pathways to CD4 T cells.3
The simplification is useful but not absolute—specialized antigen-presentation pathways can cross those usual boundaries. For an MCAT question, follow the presentation pathway explicitly described in the stem.
Worked application: one antigen, two recognition assays
An original protein antigen Q contains a surface antibody epitope in residues 20–28 and, after processing, a separate peptide epitope in residues 70–82 that binds the supplied MHC class II molecule. Investigators create two changes:
- Variant E: residues 20–28 are altered, but residues 70–82 and total protein abundance are unchanged.
- APC-M: antigen Q is taken up normally, but the antigen-presenting cell lacks functional MHC class II surface expression.
| Condition | Anti-Q antibody binding | Q uptake by APC | Q-peptide/MHC-II display | Q-specific CD4 T-cell activation |
|---|---|---|---|---|
| Reference Q + normal APC | High | Normal | Present | High |
| Variant E + normal APC | Low | Normal | Present | High |
| Reference Q + APC-M | High | Normal | Absent | Low |
Variant E disrupts the antibody epitope, so antibody binding falls. Because the distinct peptide epitope used for MHC II presentation is unchanged, T-cell activation remains high. APC-M is the opposite logic: intact antigen is present and can still bind antibody, but the APC cannot display the relevant peptide–MHC II complex, so the supplied CD4 T-cell response is lost.
The experiment does not show that Variant E is globally “invisible” to immunity. It selectively alters the measured antibody epitope while preserving the measured T-cell epitope.
Rule: antigen presence and antigen presentation are different claims
Detecting antigen inside a cell does not prove that a particular peptide is displayed on the required MHC molecule. Processing, peptide loading, MHC expression, trafficking, and receptor recognition are separate steps. Conversely, T-cell activation by a defined peptide–MHC complex can occur even when an antibody used in a different assay fails to bind the intact antigen.
Self-tolerance uses additional selection and regulatory mechanisms to limit responses against self. Loss of tolerance can contribute to autoimmunity, but one positive self-reactive antibody measurement is not enough to define an entire autoimmune mechanism without the rest of the evidence.
ACTIVE PRACTICE · IMMUNOLOGY EVIDENCE
Separate Antibody Recognition From Antigen Presentation
In the original experiment, protein Q has an antibody epitope at residues 20–28 and a distinct peptide epitope at residues 70–82 that binds the supplied MHC class II. Variant E alters only residues 20–28. APC-M lacks functional surface MHC II.
Antibody binding high; antigen uptake normal; peptide/MHC-II display present; CD4 T-cell activation high.
“High” and “low” are the qualitative experimental readouts supplied by the lesson, not quantitative predictions of absolute immune response. Other immune pathways are not ruled out.
Check your reasoning
Choose an answer before opening its feedback.
Check 1
A mutation changes an exposed antibody epitope but leaves the separate peptide presented on MHC II unchanged. Which result is most plausible?
A. Antibody binding can fall while the supplied CD4 T-cell response remains intact.
Correct. The two assays recognize different antigen features.
B. Every immune response must disappear.
Review this choice. Only one antibody epitope is stated to change.
C. MHC II becomes a soluble antibody.
Review this choice. MHC and antibody are distinct protein systems.
D. The antigen must be absent from the sample.
Review this choice. The mutation changes an epitope, not total protein abundance.
Check 2
An APC takes up antigen normally but cannot express MHC class II on its surface. Which measured response is most directly impaired in the simplified model?
A. Activation of a CD4 T cell that requires the peptide–MHC II complex
Correct. The required presenting complex cannot reach the surface.
B. All antibody molecules instantly lose their heavy chains.
Review this choice. MHC II expression does not define antibody chain structure.
C. The antigen can no longer exist extracellularly.
Review this choice. Antigen uptake and antigen existence are distinct from MHC display.
D. Every nucleated cell loses MHC I.
Review this choice. The manipulation is specific to MHC II in the supplied APC.
Check 3
Which pair is correctly matched under the standard simplified presentation model?
A. MHC I — CD8 T cell
Correct. MHC I primarily presents intracellularly derived peptides to CD8 T cells.
B. MHC II — red blood cell
Review this choice. Mature red blood cells are not professional antigen-presenting cells.
C. Antibody Fc region — DNA polymerase
Review this choice. These are unrelated functions.
D. T-cell receptor — free intact antigen only, without MHC
Review this choice. Conventional T-cell receptors recognize peptide–MHC complexes.
Continue learning
- Protein binding and cooperativity
- Protein folding and stability
- Experimental Controls
- Browse Biology & Biochemistry MCAT lessons